- William E. Lyddane
- Jonathan R. Miller*
- Daniel B. Moon
- Robert W. Mueller
- Sean C. Myers-Payne, Ph.D.
- Naoko Ohashi*
- Enoch E. Peavey
- P. Branko Pejic*
- William Pieprz
- Steven Pollicoff*
- John Preta*
- James L. Rowland
- Stephen M. Roylance
- Kenneth H. Salen
- Walter Schlapkohl, Ph.D.
- Bruce H. Stoner, Jr.
- Arnold Turk
- Christopher L. Wright, Ph.D.*
- Patent Agents
- Patent Specialists
Michael J. Fink
Firm Practice Areas/Practice Groups
Litigation and Trial
Post-Grant Patent Group
Interference and Derivation
Client Counseling, Licensing and Technology Transfer
Portfolio Management and Due Diligence
Patent Attorney - Greenblum and Bernstein, P.L.C. - 1988-Present
U.S. Department of Justice, Trial Attorney - 1984-1988
Author, Greenblum and Bernstein, P.L.C. Litigation Newsletter
Lectures on patent litigation, post grant and inter partes review proceedings, and patent monetization
Speaker at international conferences
Argued numerous appeals to U.S. Court of Appeals for the Federal Circuit.
Lead counsel in post grant and inter partes review proceedings before USPTO.
Lead or backup counsel in numerous Interference proceedings before USPTO.
Experienced in multi-party litigations and joint defense groups.
Conducted numerous patent licensing negotiations.
Professional Associations and MembershipsAmerican Bar Association
American Intellectual Property Law Association
Federal Circuit Bar Association
Licensing Executives Society
PTAB Bar Association
Fink, M., (2017). “8399514Update: IPRs Involving Biotech and Pharmaceutical Patents”, 13 Journal of Generic Medicines 137-143.
Bruce H Bernstein, Michael J Fink and P Branko Pejic (2011, 2012 and 2013 Editions). Getting the Deal Through, Licensing in the United States.
Fink, M., (2012). “Substantive Federal Circuit decisions concerning pharmaceutical companies.” 9(2) Journal of Generic Medicines 86-94.
Stoner, B., Hon., Fink. M., Bailey, N., (2009). “Re-examination Proceedings Post-KSR in the Generic Medicine Industry.” 7-1 Journal of Generic Medicines 92-101.
Greenblum, N., Fink, M., Roylance, S., Pejic, P.B., Myers- Payne, S.C., Braier, P., (2008). “Generic Drugs in a Changing Intellectual Property Landscape.” The Pharmaceutical Regulatory Process, Second Edition, pps. 143-180, Ira R. Berry and Robert P. Martin, eds., Informa Health Care
Fink, M., (2007). “US Legal and Regulatory Update: Preliminary Injunctions in Pharmaceutical Cases.” 4 Journal of Generic Medicines 213-21.
EducationMassachusetts Institute of Technology, B.S. in Chemical Engineering (1981)
Albany Law School of Union University, J.D. (1984)
U.S. Supreme Court
U.S. Court of Appeals for the Federal Circuit
U.S. District Court for the Eastern District of Virginia
U.S. District Court for the District of Columbia
1985, New York
1988, District of Columbia